- Home
- NRIM vs PRME Comparison
NRIM vs PRME Comparison
Compare NRIM & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIM | PRME |
|---|---|---|
| Founded | 1990 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 571.6M | 666.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | NRIM | PRME |
|---|---|---|
| Price | $25.26 | $3.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.42 |
| AVG Volume (30 Days) | 246.3K | ★ 2.8M |
| Earning Date | 01-23-2026 | 02-27-2026 |
| Dividend Yield | ★ 2.52% | N/A |
| EPS Growth | ★ 73.41 | N/A |
| EPS | ★ 2.87 | N/A |
| Revenue | ★ $208,902,000.00 | $5,977,000.00 |
| Revenue This Year | $4.98 | $95.64 |
| Revenue Next Year | $7.40 | N/A |
| P/E Ratio | $8.84 | ★ N/A |
| Revenue Growth | 37.50 | ★ 647.13 |
| 52 Week Low | $16.18 | $1.11 |
| 52 Week High | $30.82 | $6.94 |
Technical Indicators
Market Signals| Indicator | NRIM | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 46.95 | 39.73 |
| Support Level | $24.60 | $3.20 |
| Resistance Level | $26.26 | $3.50 |
| Average True Range (ATR) | 0.89 | 0.30 |
| MACD | 0.08 | -0.07 |
| Stochastic Oscillator | 77.81 | 8.09 |
Price Performance
Historical ComparisonAbout NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.